Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies

In the context of allogeneic transplant platforms, human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) represents one of the latest and most promising curative strategies for patients affected by high-risk hematologic malignancies. Indeed, this platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaghi, Elisa, Calvi, Michela, Di Vito, Clara, Mavilio, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892976/
https://www.ncbi.nlm.nih.gov/pubmed/31849972
http://dx.doi.org/10.3389/fimmu.2019.02794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892976/
https://www.ncbi.nlm.nih.gov/pubmed/31849972
http://dx.doi.org/10.3389/fimmu.2019.02794

Ejemplares similares